search
Back to results

Usability Study of "ArmAssist 2.0." Robot: Homecare Arm Rehabilitation in Stroke Patients (PUAA)

Primary Purpose

Stroke, Rehabilitation, Upper Limb Rehabilitation

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
ArmAssist
Sponsored by
Maimónides Biomedical Research Institute of Córdoba
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke focused on measuring Stroke, Cerebrovascular Disorders, Robotic

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Subjects over 18,
  • Upper limb hemiparesis after stroke,
  • Unilateral paresis and cognitive ability to understand,
  • Accept and actively participate in the usability study.

Exclusion Criteria:

  • Bilateral motor deficit,
  • Severe spasticity,
  • Psychiatric illness,
  • and/or cognitive impairment.

Sites / Locations

  • Hospital Universitario Reina Sofía de Córdoba

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

ArmAssist group

Arm Description

The post-stroke patients who participate in the study, are classified in differents stages (3 patients in each stage). Group 1: subacute, between 2 - 6 months Group 2: chronic of short evolution, between 6 - 12 months Group 3: long-term chronic, more than 12 months. The system is tested in a clinical (training) and patients' home setting. The ArmAssist system includes the ArmAsist 2.0 device (without motors), the tele rehabilitation platform based on serious games and Antari's HomeCare tele-care platform for the clinicians.

Outcomes

Primary Outcome Measures

Quebec User Evaluation of Satisfaction with assistive Technology: QUEST scale
The purpose of this scale is to evaluate how satisfied the patient are with the assistive device and the related services they experienced. It consists of twelve questions, eight related to the device and four related to services of 12 satisfaction items with answers from 1 'Not satisfied at all' to 5 'Very satisfied'
System Usability Scale: SUS
This scale provides a quick, reliable tool for measuring the usability. It consists of 10 item questionnaire and answers from 1 'strongly agree' to 5 'strongly disagree'. Scores are ranging to 0-100 %, where a high score means better usability with a higher score meaning better usability
Intrinsic Motivation Inventory: IMI
This scale is a multidimensional scale intended to assess participants subjective experience with the device (interest/enjoyment, perceived competence, effort, value/usefulness, felt pressure and tension, and perceived choice while performing a given activity). Consist of 20 item questionnaire with answers from 1 'strongly agree' to 7 'strongly disagree'.
Usability questionnaire specifically designed for the use of ArmAssist 2.0
It consists of a 19 item questionnaire with seven response options (Likert sacle) for respondents; from Strongly agree to Strongly disagree. To evaluate the satisfaction of patients and therapist with the system and the therapy.
Structured interviews: Willingness-to-pay questionnaire
This interview consists in two short questions to ask to participants about the willingness-to-pay for ArmAssist 2.0. system as therapy.

Secondary Outcome Measures

Fugl-Meyer Assessment (FMA) scale
It is an index to assess the sensorimotor impairment in individuals who have had stroke. The Fugl-Meyer Assessment scale is an ordinal scale that has 3 points for each item. A zero score is given for the item if the subject cannot do the task. A score of 1 is given when the task is performed partially and a score of 2 is given when the task is performed fully. The maximun score is 66 points
Modified Asworth Scale (MAS)
This scale measures resistance during passive soft-tissue stretching and is used as a simple measure of spasticity. It is single-item measures ranging from 0 to 4, where 0 indicates no increase in muscle tone and 4 indicates that the affected part is rigid in flexion or extension.

Full Information

First Posted
May 19, 2020
Last Updated
June 1, 2020
Sponsor
Maimónides Biomedical Research Institute of Córdoba
Collaborators
TECNALIA Research & Innovation, GMV Innovating Solutions
search

1. Study Identification

Unique Protocol Identification Number
NCT04405609
Brief Title
Usability Study of "ArmAssist 2.0." Robot: Homecare Arm Rehabilitation in Stroke Patients
Acronym
PUAA
Official Title
Usability Study of "ArmAssist 2.0." Robot: Homecare Arm Rehabilitation in Acute, Subacute and Chronic Stroke Patients
Study Type
Interventional

2. Study Status

Record Verification Date
June 2020
Overall Recruitment Status
Completed
Study Start Date
October 28, 2019 (Actual)
Primary Completion Date
December 30, 2019 (Actual)
Study Completion Date
December 30, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Maimónides Biomedical Research Institute of Córdoba
Collaborators
TECNALIA Research & Innovation, GMV Innovating Solutions

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to validate the usability of ArmAssist medical device, a robotic system for the rehabilitation of upper limbs in stroke patients (based on serious games). This study evaluate the usability of the system in a home environment, taking into account the ease-to-use, consistency and others; and will pretend demonstrate the feasibility of including or no, robotic therapy in home like complement of daily rehabilitation program. Finally this study investigate the acceptance from patients and therapists.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke, Rehabilitation, Upper Limb Rehabilitation, Telerehabilitation, Robot-assisted Therapy
Keywords
Stroke, Cerebrovascular Disorders, Robotic

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
9 (Actual)

8. Arms, Groups, and Interventions

Arm Title
ArmAssist group
Arm Type
Experimental
Arm Description
The post-stroke patients who participate in the study, are classified in differents stages (3 patients in each stage). Group 1: subacute, between 2 - 6 months Group 2: chronic of short evolution, between 6 - 12 months Group 3: long-term chronic, more than 12 months. The system is tested in a clinical (training) and patients' home setting. The ArmAssist system includes the ArmAsist 2.0 device (without motors), the tele rehabilitation platform based on serious games and Antari's HomeCare tele-care platform for the clinicians.
Intervention Type
Device
Intervention Name(s)
ArmAssist
Intervention Description
The usability study protocol include 3 ArmAssist systems (2 designed for the left hand and one for the right hand) that could not be used in parallel because the aim of the study was to bring the systems to the home environment during part of the evaluation. The usability study is carried out in two phases: First phase: 5 weeks. Second phase: 3 weeks. Each phase included a week of training at the Hospital or IMIBIC facilities with a physiotherapist, and then 2 weeks at the patient's home, being the first one with the physiotherapist supervision and the second one by their own with the possibility of physiotherapist remote support.
Primary Outcome Measure Information:
Title
Quebec User Evaluation of Satisfaction with assistive Technology: QUEST scale
Description
The purpose of this scale is to evaluate how satisfied the patient are with the assistive device and the related services they experienced. It consists of twelve questions, eight related to the device and four related to services of 12 satisfaction items with answers from 1 'Not satisfied at all' to 5 'Very satisfied'
Time Frame
Through study completion, an average of 3 weeks
Title
System Usability Scale: SUS
Description
This scale provides a quick, reliable tool for measuring the usability. It consists of 10 item questionnaire and answers from 1 'strongly agree' to 5 'strongly disagree'. Scores are ranging to 0-100 %, where a high score means better usability with a higher score meaning better usability
Time Frame
Through study completion, an average of 3 weeks
Title
Intrinsic Motivation Inventory: IMI
Description
This scale is a multidimensional scale intended to assess participants subjective experience with the device (interest/enjoyment, perceived competence, effort, value/usefulness, felt pressure and tension, and perceived choice while performing a given activity). Consist of 20 item questionnaire with answers from 1 'strongly agree' to 7 'strongly disagree'.
Time Frame
Through study completion, an average of 3 weeks
Title
Usability questionnaire specifically designed for the use of ArmAssist 2.0
Description
It consists of a 19 item questionnaire with seven response options (Likert sacle) for respondents; from Strongly agree to Strongly disagree. To evaluate the satisfaction of patients and therapist with the system and the therapy.
Time Frame
Through study completion, an average of 3 weeks
Title
Structured interviews: Willingness-to-pay questionnaire
Description
This interview consists in two short questions to ask to participants about the willingness-to-pay for ArmAssist 2.0. system as therapy.
Time Frame
Through study completion, an average of 3 weeks
Secondary Outcome Measure Information:
Title
Fugl-Meyer Assessment (FMA) scale
Description
It is an index to assess the sensorimotor impairment in individuals who have had stroke. The Fugl-Meyer Assessment scale is an ordinal scale that has 3 points for each item. A zero score is given for the item if the subject cannot do the task. A score of 1 is given when the task is performed partially and a score of 2 is given when the task is performed fully. The maximun score is 66 points
Time Frame
Baseline, 3 weeks
Title
Modified Asworth Scale (MAS)
Description
This scale measures resistance during passive soft-tissue stretching and is used as a simple measure of spasticity. It is single-item measures ranging from 0 to 4, where 0 indicates no increase in muscle tone and 4 indicates that the affected part is rigid in flexion or extension.
Time Frame
Baseline, 3 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Subjects over 18, Upper limb hemiparesis after stroke, Unilateral paresis and cognitive ability to understand, Accept and actively participate in the usability study. Exclusion Criteria: Bilateral motor deficit, Severe spasticity, Psychiatric illness, and/or cognitive impairment.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Fernando Jesus Mayordomo Riera, MD
Organizational Affiliation
Hospital Universitario Reina Sofia de Córdoba
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Universitario Reina Sofía de Córdoba
City
Córdoba
ZIP/Postal Code
14004
Country
Spain

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
All the collected information will be available for other researchers upon request.
IPD Sharing Time Frame
Up to 12 months after trials publication.
IPD Sharing Access Criteria
Request by e-mail to uicec@imibic.org
Citations:
PubMed Identifier
33622344
Citation
Guillen-Climent S, Garzo A, Munoz-Alcaraz MN, Casado-Adam P, Arcas-Ruiz-Ruano J, Mejias-Ruiz M, Mayordomo-Riera FJ. A usability study in patients with stroke using MERLIN, a robotic system based on serious games for upper limb rehabilitation in the home setting. J Neuroeng Rehabil. 2021 Feb 23;18(1):41. doi: 10.1186/s12984-021-00837-z.
Results Reference
derived

Learn more about this trial

Usability Study of "ArmAssist 2.0." Robot: Homecare Arm Rehabilitation in Stroke Patients

We'll reach out to this number within 24 hrs